Vitamins and Supplements That May Help With Schizophrenia
Elaine Weiner, MD, assistant professor of psychiatry, University of Maryland Medical System.
Joshua Roffman, MD, assistant professor of psychiatry, Harvard Medical School; Director, Brain Genomics Laboratory, Massachusetts General Hospital, Boston.
Thomas Milam, MD, chief medical officer, Iris Telehealth; associate professor of psychiatry, Virginia Tech Carilion School of Medicine & Research Institute.
Current psychiatry: “Omega-3 fatty acids for psychiatric illnesses.”
Scientific reports: “The association between neonatal vitamin D status and the risk of schizophrenia.”
Journal of Clinical Endocrinology and Metabolism: “Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational Studies.”
BMC tests: “Vitamin D Supplementation Versus Placebo in People With First-Episode Psychosis – Neuroprotection Design (DFEND): A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial.”
Cambridge Core: “The Effects of Vitamin and Mineral Supplementation on Symptoms of Schizophrenia: A Systematic Review and Meta-Analysis.”
JAMA Psychiatry: “Randomized multicenter investigation into folate and vitamin B12 supplementation in schizophrenia.”
Molecular psychiatry: “Biochemical, physiological and clinical effects of L-methylfolate in schizophrenia: a randomized controlled trial.”
Cochrane Library: “Vitamin E for tardive dyskinesia induced by antipsychotics.”
Brain, behavior and immunity: “Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled longitudinal pilot study.”
BMC Psychiatry: “Clinical and metabolic response to vitamin D plus probiotic in schizophrenic patients.”
Our sincere thanks to